Pharmaceutical preparations for treatment of proliferative diseases, namely, pharmaceutical preparations for treatment of cancer, tumors, carcinoma or blastoma; pharmaceutical preparations comprising an anti-VEGF (vascular endothelial growth factor) monoclonal antibody, namely, pharmaceutical preparations comprising an anti-VEGF (vascular endothelial growth factor) monoclonal antibody for treatment of cancer, tumors, carcinoma or blastoma